Cargando…

Lung immune signatures define two groups of end-stage IPF patients

BACKGROUND: The role of the immune system in the pathobiology of Idiopathic Pulmonary Fibrosis (IPF) is controversial. METHODS: To investigate it, we calculated immune signatures with Gene Set Variation Analysis (GSVA) and applied them to the lung transcriptome followed by unbiased cluster analysis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cruz, Tamara, Mendoza, Núria, Casas-Recasens, Sandra, Noell, Guillaume, Hernandez-Gonzalez, Fernanda, Frino-Garcia, Alejandro, Alsina-Restoy, Xavi, Molina, María, Rojas, Mauricio, Agustí, Alvar, Sellares, Jacobo, Faner, Rosa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540496/ https://www.ncbi.nlm.nih.gov/pubmed/37770891 http://dx.doi.org/10.1186/s12931-023-02546-8

Ejemplares similares

Blood Immunophenotypes of Idiopathic Pulmonary Fibrosis: Relationship with Disease Severity and Progression
por: Mendoza, Nuria, et al.
Publicado: (2023)

Cellular Senescence in Lung Fibrosis
por: Hernandez-Gonzalez, Fernanda, et al.
Publicado: (2021)

From systems biology to P4 medicine: applications in respiratory medicine
por: Noell, Guillaume, et al.
Publicado: (2018)

Persistence of a SARS-CoV-2 T-cell response in patients with long COVID and lung sequelae after COVID-19
por: Cruz, Tamara, et al.
Publicado: (2023)

Multi-level immune response network in mild-moderate Chronic Obstructive Pulmonary Disease (COPD)
por: Cruz, Tamara, et al.
Publicado: (2019)

Functional Criteria to Define Progressive Pulmonary Fibrosis: Searching for the Holy Grail
por: Noboa-Sevilla, María, et al.
Publicado: (2022)

SARS-CoV-2 T-cell response in COVID-19 convalescent patients with and without lung sequelae
por: Cruz, Tamara, et al.
Publicado: (2022)

Molecular Interactions of SARS-CoV-2 in Lung Tissue of Patients with Chronic Obstructive Pulmonary Disease
por: Agusti, Alvar, et al.
Publicado: (2021)

Elevated plasma levels of epithelial and endothelial cell markers in COVID-19 survivors with reduced lung diffusing capacity six months after hospital discharge
por: Sibila, Oriol, et al.
Publicado: (2022)

Do sputum or circulating blood samples reflect the pulmonary transcriptomic differences of COPD patients? A multi-tissue transcriptomic network META-analysis
por: Faner, Rosa, et al.
Publicado: (2019)

Towards a global initiative for fibrosis treatment (GIFT)
por: Molina-Molina, Maria, et al.
Publicado: (2017)

Telomere Length but Not Mitochondrial DNA Copy Number Is Altered in Both Young and Old COPD
por: Casas-Recasens, Sandra, et al.
Publicado: (2021)

Liver epigenome changes in patients with hepatopulmonary syndrome: A pilot study
por: Mendoza, Nuria, et al.
Publicado: (2021)

Systemic Inflammatory Response to Smoking in Chronic Obstructive Pulmonary Disease: Evidence of a Gender Effect
por: Faner, Rosa, et al.
Publicado: (2014)

Lung Function sequelae in COVID-19 Patients 3 Months After Hospital Discharge
por: Sibila, Oriol, et al.
Publicado: (2021)

When Harry Met Sally, or When Machine Learning Met Chronic Obstructive Pulmonary Disease
por: Agusti, Alvar, et al.
Publicado: (2020)

The EASI model: A first integrative computational approximation to the natural history of COPD
por: Agustí, Alvar, et al.
Publicado: (2017)

Bone marrow characterization in COPD: a multi-level network analysis
por: Toledo-Pons, Nuria, et al.
Publicado: (2018)

Early treatment with inhaled budesonide to prevent clinical deterioration in patients with COVID-19
por: Agusti, Alvar, et al.
Publicado: (2021)

Acute exacerbations of idiopathic pulmonary fibrosis: Does clinical stratification or steroid treatment matter?
por: Cuerpo, Sandra, et al.
Publicado: (2019)

Human senescent fibroblasts trigger progressive lung fibrosis in mice
por: Hernandez-Gonzalez, Fernanda, et al.
Publicado: (2023)

COVID-19 and lung involvement
por: You, Jin-Seok, et al.
Publicado: (2022)

Reply to Guo et al.
por: Wang, Gang, et al.
Publicado: (2023)

Estudio histológico mediante biopsia pulmonar post mortem en pacientes con neumonía por COVID-19
por: Sellarés, Jacobo, et al.
Publicado: (2022)

[Translated article] Histology Study of Postmortem Lung Biopsies in Patients With Covid-19 Pneumonia
por: Sellarés, Jacobo, et al.
Publicado: (2022)

Do chronic respiratory diseases or their treatment affect the risk of SARS-CoV-2 infection?
por: Halpin, David M G, et al.
Publicado: (2020)

Characterization, localization and comparison of c-Kit+ lung cells in never smokers and smokers with and without COPD
por: López-Giraldo, Alejandra, et al.
Publicado: (2018)

Development of the ATAQ-IPF: a tool to assess quality of life in IPF
por: Swigris, Jeffrey J, et al.
Publicado: (2010)

Recommendations on treatment for IPF
por: Behr, Jürgen, et al.
Publicado: (2013)

Gastroesophageal reflux and antacid therapy in IPF: analysis from the Australia IPF Registry
por: Jo, Helen E., et al.
Publicado: (2019)

Serum Progranulin Level Might Differentiate Non-IPF ILD from IPF
por: Tóth, Nóra Melinda, et al.
Publicado: (2023)

Building Strong Neighborhoods in the Lung with a Little Help from My Mesenchymal Stem Cells
por: Faner, Rosa, et al.
Publicado: (2019)

An investigation of the resolution of inflammation (catabasis) in COPD
por: Noguera, Aina, et al.
Publicado: (2012)

Inhaled corticosteroids for the treatment of COVID-19
por: Bafadhel, Mona, et al.
Publicado: (2022)

Highlights of HRCT imaging in IPF
por: Sverzellati, N
Publicado: (2013)

IPF - Idiopathic Pulmonary Fibrosis
Publicado: (2019)

The role of neutrophils in the pathogenesis of IPF
por: Jegal, Yangjin
Publicado: (2022)

Sarcoidosis Phenotypes
por: Francesqui, Joel, et al.
Publicado: (2021)

Rapidly non-ipf progressive fibrosing interstitial lung disease: a phenotype with an ipf-like behavior
por: Khine, Ngu, et al.
Publicado: (2020)

Further Defining the Human Virome using NGS: Identification of Redondoviridae
por: Noell, Kristin, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ruvgcd62gvqvgcmr919mf09ds4